High efficacy of docetaxel with and without androgen deprivation and estramustine in preclinical models of advanced prostate cancer.
High efficacy of docetaxel with and without androgen deprivation and estramustine in preclinical models of advanced prostate cancer. Anticancer Res. 2004 Sep-Oct; 24(5A):2897-903.